🔎 Trials Near Me

Home › HIV › NCT06927856

The Test-to-PrEP Study

RecruitingHealthy volunteers welcome

Test-to-PrEP: A Randomized Hybrid Implementation/Effectiveness Trial of a Social Network Strategy to Increase Equitable Reach of HIV Testing and PrEP Information

Who can join

Ages 18 and older · All sexes · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria - PrEP Clients (Egos):

* Stated willingness to provide informed consent.
* Stated willingness to comply with all study procedures.
* Stated availability for the duration of the study.
* Ability to identify members of their social network who may benefit from receiving an HIVST kit and PrEP information.
* Currently prescribed PrEP by RAPID clinics, including those initiating PrEP on the same day as study enrollment.

Inclusion Criteria for Peers (Alters):

\- Provision of electronic informed consent prior to completion of the Quick Response (QR)-linked survey instruments.

Exclusion Criteria for PrEP Clients (Egos):

* Inability or refusal to provide informed consent (e.g., cognitive impairment).
* Unable or unwilling to comply with study procedures per study investigator
* Inability to identify members of their social network who may benefit from receiving an HIVST kit and PrEP information.
* Aged 17 years or younger.

Exclusion Criteria for Peers (Alters):

* Failure to provide electronic informed consent prior to starting QR-linked Alter survey tools.
* Age 17 years or younger.

About the study

To compare the effectiveness of two social network strategies (direct distribution and referral-based distribution) in increasing HIV self-testing (HIVST) completion rates among social network contacts of current Pre-Exposure Prophylaxis (PrEP) clients.

What is being tested

Sponsor: University of Miami · Participants: 320 · Started: Apr 10, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT06927856

Locations in the U.S.

FloridaUniversity of Miami, Miami

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.